Загрузка...
Mutational signatures in squamous cell carcinoma of the lung
BACKGROUND: Tumor mutational burden (TMB) has been identified as one of the predictors for the response to anti-programmed cell death-1 (anti-PD-1) antibody therapy and reported to correlate with smoking history in lung adenocarcinoma. However, in squamous cell carcinoma of the lung, the association...
Сохранить в:
| Опубликовано в: : | J Thorac Dis |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7947495/ https://ncbi.nlm.nih.gov/pubmed/33717580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-20-2602 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|